share_log

Watching Palisade Bio; Ladenburg Gives Stock Buy Rating And $25 Price Target Says Spoke to Pali Management, Growing More Confident In The Regulatory Path LB1148 May Take Forward As The Topline Ph2 Data On The Prevention Of Post-surgical Abdominal Adhesion

Benzinga Real-time News ·  Feb 1, 2023 02:41
Watching Palisade Bio; Ladenburg Gives Stock Buy Rating And $25 Price Target Says Spoke to Pali Management, Growing More Confident In The Regulatory Path LB1148 May Take Forward As The Topline Ph2 Data On The Prevention Of Post-surgical Abdominal Adhesion
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment